Literature DB >> 19020950

Extranodal multifocal Rosai-Dorfman disease: response to 2-chlorodeoxyadenosine treatment.

Ceyla Konca1, Zübeyde N Özkurt2, Müge Deger3, Zeynep Akı2, Münci Yağcı2.   

Abstract

Rosai-Dorfman disease (RDD) or "sinus histiocytosis with massive lymphadenopathy" is a rare lymphoproliferative disorder of unknown etiology. The disease usually presents with painless lymphadenopathy with occasional extranodal involvement in various organs. We report a case of a 36-year-old man with a history of non-Hodgkin lymphoma (NHL), who recently presented with inguinal lymphadenopathy. Following the diagnosis of RDD on lymph node biopsy, he developed symptoms of spinal cord compression due to a mass lesion discovered at T6-7 vertebral level. 18F-Fluorodeoxyglucose (18FDG) positron emission tomography (PET-CT) revealed extensive disease with lung, renal and bone involvement. The patient received a short course of steroid therapy for cord compression findings and 2-chlorodeoxyadenosine (2-CdA) treatment was initiated for long-term disease control. He had a dramatic sustained response to treatment with six courses of 2-CdA. These results suggest that 2-CdA can be an effective treatment of choice and positron emission tomography with 18FDG can be used for determining the extent of disease and for follow-up in RDD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19020950     DOI: 10.1007/s12185-008-0192-2

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  37 in total

1.  Egg shell nodal calcification in a patient with sinus histiocytosis with massive lymphadenopathy treated with interferon.

Authors:  A R Silvers; P M Som; R J Meyer
Journal:  AJNR Am J Neuroradiol       Date:  1996-02       Impact factor: 3.825

2.  Venorelbine and methotrexate for the treatment of Rosai-Dorfman disease.

Authors:  Susumu Inoue; Nkechi Onwuzurike
Journal:  Pediatr Blood Cancer       Date:  2005-07       Impact factor: 3.167

3.  Extensive purely cutaneous Rosai-Dorfman disease responsive to acitretin.

Authors:  Amel Mebazaa; Sabiha Trabelsi; Mohamed Denguezli; Badreddine Sriha; Colandane Belajouza; Rafia Nouira
Journal:  Int J Dermatol       Date:  2007-11       Impact factor: 2.736

4.  Rosai-Dorfman disease presenting as extranodal renal mass.

Authors:  Anand Krishnan; Aziza Nassar; Peter T Nieh
Journal:  Urology       Date:  2005-12       Impact factor: 2.649

Review 5.  Sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease): report of a patient with isolated renotesticular involvement after cure of non-Hodgkin's lymphoma.

Authors:  I S Lossos; E Okon; V Bogomolski-Yahalom; N Ron; A Polliack
Journal:  Ann Hematol       Date:  1997-01       Impact factor: 3.673

6.  Sinus histiocytosis with massive lymphadenopathy: a pseudolymphomatous benign disorder. Analysis of 34 cases.

Authors:  J Rosai; R F Dorfman
Journal:  Cancer       Date:  1972-11       Impact factor: 6.860

7.  Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity.

Authors:  J Rosai; R F Dorfman
Journal:  Arch Pathol       Date:  1969-01

8.  Imatinib as a treatment option for systemic non-Langerhans cell histiocytoses.

Authors:  Jochen Utikal; Selma Ugurel; Hjalmar Kurzen; Philipp Erben; Andreas Reiter; Andreas Hochhaus; Thomas Nebe; Ralf Hildenbrand; Uwe Haberkorn; Sergij Goerdt; Dirk Schadendorf
Journal:  Arch Dermatol       Date:  2007-06

9.  PET imaging of Rosai-Dorfman disease: correlation with histopathology and ex-vivo beta-imaging.

Authors:  Christian Menzel; Nadja Hamscho; Natascha Döbert; Frank Grünwald; Adorján F Kovács; Manfred Wolter; Maurizio Podda
Journal:  Arch Dermatol Res       Date:  2003-10-18       Impact factor: 3.017

10.  Benign sinus histiocytosis with massive lymphadenopathy: transient immunological defects in a child with mediastinal involvement.

Authors:  D M Becroft; M R Dix; J C Gillman; B J MacGregor; R L Shaw
Journal:  J Clin Pathol       Date:  1973-07       Impact factor: 3.411

View more
  10 in total

1.  The use of FDG-PET/CT in extranodal Rosai-Dorfman disease of bone.

Authors:  Jeffrey S Tsang; Marina-Portia Anthony; Maria P Wong; C S Wong
Journal:  Skeletal Radiol       Date:  2012-03-27       Impact factor: 2.199

Review 2.  Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.

Authors:  Oussama Abla; Eric Jacobsen; Jennifer Picarsic; Zdenka Krenova; Ronald Jaffe; Jean-Francois Emile; Benjamin H Durham; Jorge Braier; Frédéric Charlotte; Jean Donadieu; Fleur Cohen-Aubart; Carlos Rodriguez-Galindo; Carl Allen; James A Whitlock; Sheila Weitzman; Kenneth L McClain; Julien Haroche; Eli L Diamond
Journal:  Blood       Date:  2018-05-02       Impact factor: 22.113

Review 3.  Spinal Rosai-Dorfman disease: case report and literature review.

Authors:  Haocheng Xu; Fan Zhang; Feizhou Lu; Jianyuan Jiang
Journal:  Eur Spine J       Date:  2017-02-06       Impact factor: 3.134

4.  Primary Rosai-Dorfman disease of the femur.

Authors:  Jonathan C Baker; Michael Kyriakos; Douglas J McDonald; David A Rubin
Journal:  Skeletal Radiol       Date:  2016-10-26       Impact factor: 2.199

5.  Rosai-Dorfman Disease with nodal and extranodal involvements: A case report.

Authors:  Mehri Najafi-Sani; Hossein Saneian; Fatemeh Mahjoub
Journal:  J Res Med Sci       Date:  2011-09       Impact factor: 1.852

6.  A single case of rosai-dorfman disease marked by pathologic fractures, kidney failure, and liver cirrhosis treated with single-agent cladribine.

Authors:  Koji Sasaki; Naveen Pemmaraju; Jason R Westin; Wei-Lien Wang; Joseph D Khoury; Donald A Podoloff; Bryan Moon; Naval Daver; Gautam Borthakur
Journal:  Front Oncol       Date:  2014-10-29       Impact factor: 6.244

7.  A new case of cervical intramedullary sinus histiocytosis causing paraplegia and review of the literature.

Authors:  Jesús Rocha-Maguey; José-Angel Felix-Torrontegui; Myriam Cabrera-López; Macrina Gutiérrez-Castro; Daniel Montante-Montes de Oca
Journal:  Surg Neurol Int       Date:  2016-01-28

8.  Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease.

Authors:  Gaurav Goyal; Aishwarya Ravindran; Jason R Young; Mithun V Shah; N Nora Bennani; Mrinal M Patnaik; Grzegorz S Nowakowski; Gita Thanarajasingam; Thomas M Habermann; Robert Vassallo; Taimur Sher; Sameer A Parikh; Karen L Rech; Ronald S Go
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

Review 9.  Diagnosis and treatment of Rosai-Dorfman disease of the spine: a systematic literature review.

Authors:  Pan-Pan Hu; Feng Wei; Xiao-Guang Liu; Zhong-Jun Liu
Journal:  Syst Rev       Date:  2021-01-18

10.  Rosai-Dorfman disease mimicking images of meningiomas: Two case reports and literature review.

Authors:  Rafael Trindade Tatit; Paulo Eduardo Albuquerque Zito Raffa; Giovana Cassia de Almeida Motta; André Alexandre Bocchi; Júlia Loripe Guimaraes; Paulo Roberto Franceschini; Paulo Henrique Pires de Aguiar
Journal:  Surg Neurol Int       Date:  2021-06-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.